Pharmacology · Antidiabetic Drugs (Oral Hypoglycemics, Insulins)

Acarbose is added to a diabetic patient's regimen. Two weeks later he complains of excessive flatulence and bloating. Which mechanism of acarbose directly explains these gastrointestinal side effects?

  • A It chelates dietary carbohydrates in the gastric lumen
  • B It stimulates cholecystokinin release, increasing gallbladder contraction
  • C It reduces gastric emptying through GLP-1 potentiation
  • D It inhibits alpha-glucosidase in the small intestinal brush border, causing carbohydrate fermentation by colonic bacteria
Correct answer: D. It inhibits alpha-glucosidase in the small intestinal brush border, causing carbohydrate fermentation by colonic bacteria

Explanation

Acarbose inhibits alpha-glucosidase enzymes on the small intestinal brush border, delaying carbohydrate digestion and absorption. Undigested carbohydrates reach the colon where bacterial fermentation produces gas, causing flatulence, bloating, and diarrhea. These dose-related GI effects are the main reason for poor tolerability and discontinuation.

Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs

See all Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs →